RGH 1962
Alternative Names: GYKI 39541Latest Information Update: 08 Nov 2006
At a glance
- Originator Gedeon Richter; Nonindustrial source
- Class Antithrombotics; Small molecules
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 08 Nov 2006 Discontinued - Preclinical for Thrombosis in Hungary (PO)
- 08 Jun 1999 New profile
- 08 Jun 1999 Preclinical development for Thrombosis in Hungary (PO)